Quality & Outcomes
Breast Cancer
Ductal and Lobular Carcinoma in SITU by Mahesh Pandey, MD
Stage III Breast Cancer Survival Study by Dr. M. O'Rourke
Breast cancer is the most common malignancy in the
Colon Cancer
Stage IV Colon Cancer Survival Report
Colon Cancer Survival Report 2011
According to National Cancer Institute, more than 100,000 cases of colon cancer and about 40,000 cases of rectal cancer will be diagnosed in the United States in 2010. Over 50,000 patients will die from the disease in this year (1). CRC is the second leading cause of cancer death after lung cancer. The incidence of disease has declined slightly in this country since late 1990s and this is thought to be partly due to early diagnosis by screening lower endoscopy and polypectomy.
The United States has one of the lowest mortality rates of colorectal cancer (CRC) despite having a higher incidence than most countries. The collected data suggests that the five-year survival of patients in all stages of CRC is approximately 61% (3).
Lung CancerStage III-IV Non-Small Cell Lung Cancer Survival Study
Lung Cancer is one of the most common malignancies and number one cause of cancer mortality worldwide. In the United States in 2007, there will be an estimated 215,000 new cases of lung cancer and 162,000 deaths (1).
This disease is broadly divided into two major subtypes, small cell and non-small cell. Non-small cell histology accounts for more than 80% of cases.
Here, we will review the outcome of cases of advanced non-small cell lung cancer that were diagnosed and treated at St. Mary's Regional Medical Center from 1998 through 2000.
Liver CancerTreatment Approaches to Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide. It is accounted for 250,000 and one million deaths globally per year. This disease is typically diagnosed late in its course, and therefore, these patients tend to have an unfavorable outcome.
